Special Issue "Non-small Cell Lung Cancer--Tumor Biology"
Deadline for manuscript submissions: closed (30 June 2021).
Interests: chemoresistance; miRNA; apoptosis; biomarkers; cancer stem cells
Interests: molecular mechanisms that regulate cell proliferation; tumor progression; angiogenesis and metastasis; the role of nicotine in promoting growth and metastasis of tumors; cancer stem cells; mechanisms of drug resistance; novel drug targets
Special Issues and Collections in MDPI journals
Special Issue in International Journal of Molecular Sciences: Cell and Molecular Biology of Pancreatic Disorders
Special Issue in International Journal of Molecular Sciences: Advances in Pancreatic Cancer Research: Underlying Mechanisms and Therapeutic Targets
2. Clinical Service Chief|Penn State Health Hershey Medical Center, 500 University Dr. - Room C7008 MC HO83, Hershey, PA 17033, USA
Interests: tumor microenvironment; mechanisms associated with angiogenesis; invasion and metastasis; matrix interactions
Lung cancer remains the leading cause of cancer incidence and mortality among both men and women in the United States and globally, and non-small cell lung carcinoma (NSCLC) accounts for 87% of all lung cancers. The challenges of this devastating disease are manifold and range from metastatic and recurrent aggressive disease and poor response to therapeutic options and development of chemoresistance. Despite significant investigative efforts, our understanding of the underlying biology remains limited.
This Special Issue of Cancers seeks to compile a series of original research articles and timely, comprehensive reviews encompassing all aspects of lung cancer. Investigations into the myriad changes within the tumor microenvironment, including angiogenesis, invasion, epithelial–mesenchymal transition, cancer stem cells, deciphering molecular changes, and identifying biomarkers and predictors of prognosis and behavior, as well as advances in therapeutic options and resistance mechanisms, are topics of special interest. Contributions on other significant topics that further enhance our understanding of the biology of lung cancer are also welcome.
Prof. Dr. Mumtaz V. Rojiani
Prof. Dr. Srikumar Chellappan
Prof. Dr. Amyn M. Rojiani
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- tumor microenvironment
- molecular mechanisms
- therapeutic interventions